Clinical trial to assess the safety and efficacy of hair grow serum product in volunteers with hair fall and healthier hair

Abstract

All genders, ages, and ethnicities experience hair loss, which has both physical and psychological implications. The currently available synthetic drug-based conventional therapy for hair loss is still not perfect and has a number of drawbacks. Both their efficacy and the safety of their use are frequently questioned. It has spurred interest in less harmful alternative treatments, such as homeopathic formulations and/or their active ingredients. In healthy male and female volunteers with hair loss, this clinical trial was created to assess the effectiveness and safety of a hair serum formulation comprising arnica, jaborandi, Cantharis, Calandula, Embelica Off., and Bacopa mon. The study included 30 subjects in total, who used the test product every day for 90 days. The test product's effectiveness at boosting hair growth rate, hair density, anagen hair, telogen hair, and the density of vellus and terminal hair was assessed using TrichoScan®. Both dermatologists and subject self-assessment questionnaires compared hair thinning and hair fall decrease to their baseline conditions. In comparison to the baseline measurement, there was a considerable improvement in the rate of hair growth, hair density, vellus hair density, terminal hair density, hair thinning, and hair density without bulb. During the trial, adverse events were not documented. There were no reports of skin intolerance during the study, and the test product was considered dermatologically safe to use.